Company / Interest Expense per Share
Arcadia Biosciences, Inc. Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.57
FY2025
5-year range
-$0.04 / $0.57
FY2021-FY2025
Trend
+6.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Interest Expense per Share has increased for 3 consecutive years, from $-0.04 in FY2022 to $0.57 in FY2025.
Based on SEC 10-K filings.
0.57 in FY2025 with a 5-year CAGR of +297.4%.
Increased from $0.47 to $0.57 over the past 2 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +297.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s interest expense per share has grown for 3 consecutive years.
- In FY2025, interest expense per share increased 6.0% year-over-year.
- Peak interest expense per share was recorded in FY2017.
- Lowest interest expense per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.57 | +6.0% |
| FY2024 | $0.54 | +15.3% |
| FY2023 | $0.47 | +1400.8% |
| FY2022 | -$0.04 | -1132.0% |
| FY2021 | $0.00 | +504.2% |
| FY2020 | $0.00 | -44.8% |
| FY2019 | $0.00 | -99.7% |
| FY2018 | $0.35 | -41.0% |
| FY2017 | $0.59 | +885.7% |
| FY2016 | $0.06 | -91.0% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026